Furthermore, in MDS patients with normal karyotype, SRSF2 mutation was also found to predict the adverse outcome by Kaplan-Meier, univariate and multivariate Cox analyses (Fig. 5B, Table 4). Here, SRSF2 is linked to myelodysplastic syndrome.